Dr. Matthew Risendal, DO

In 2023, Dr. Matthew Risendal, DO had a list price for post void residual study, prostate-specific antigen (PSA) test, and total PSA test that was lower than the list prices billed to Medicare by 95% of providers in related specialties within Montana. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

In 2013, among providers in related specialties within Montana, Dr. Matthew Risendal, DO performed more cystoscopy, diagnostic cystoscopy, minimally invasive procedures, post void residual study, and urologic procedures procedures for Medicare patients than 75% of them and he also had a list price for antigen tests, antineoplastic hormone therapy, blood draw, blood draw for lab tests, blood tests, indwelling urethral catheter insertion, phlebotomy for lab tests, urinalysis, and venipuncture (phlebotomy) that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.